Revance Therapeutics
RVNC
#6824
Rank
C$0.63 B
Marketcap
$6.06
Share price
1.65%
Change (1 day)
-34.56%
Change (1 year)

EPS for Revance Therapeutics (RVNC)

EPS in 2023 (TTM): -$6.13

According to Revance Therapeutics's latest financial reports the company's current EPS (TTM) is -$6.37. In 2022 the company made an earnings per share (EPS) of -$6.76 a decrease over its 2021 EPS that were of -$5.88.

EPS history for Revance Therapeutics from 2013 to 2023

Annual EPS

Year EPS Change
2023 (TTM)-$6.13-9.36%
2022-$6.7615.07%
2021-$5.88-13.81%
2020-$6.8232.51%
2019-$5.15-7.11%
2018-$5.54-1.25%
2017-$5.6125.47%
2016-$4.476%
2015-$4.22-21.47%
2014-$5.370.04%
2013-$5.37

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
-$0.35-94.48%๐Ÿ‡บ๐Ÿ‡ธ USA
$19.81-410.93%๐Ÿ‡บ๐Ÿ‡ธ USA
$25.96-507.51%๐Ÿ‡บ๐Ÿ‡ธ USA